$SERA
Sera Prognostics, Inc. Class A Common Stock
XNAS•Health Care•Services-Medical Laboratories
$2.08
▲+0.72%+$0.015
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSera Prognostics, Inc. Class A Common Stock
XNAS•Health Care•Services-Medical Laboratories
Why is SERA up today? It is at $2.08 (+0.72%). See the catalyst behind the move, real-time alerts the moment SERA spikes, and full due diligence on SERA — key stats, earnings, dilution and insider activity. Free.
Be first to know when $SERA makes an unusual move. Create a free account to track $SERA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SERA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SERA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystSalt Lake City – August 19, 2026 – Sera Prognostics Inc., The PregnancyReported prematurity in the United States were estimated to be approximately $25 billion for 2016., from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 11, 2026 · 9 days agoAcross every filing on file, supply equal to 125% of the tradeable float is in play - 125% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
19,900,498 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $40.0M in size · Priced at $2.01/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lindgardt Zhenya Officer | Sold (automatic/other) | -7K 0.02% of company | sold 0.8% | 838K | $14K at $2.00 | Sep 10, 26 |
Inglis Tiffany Eul Davis Officer | Sold (automatic/other) | -486 | sold 0.5% | 92K | $972 at $2.00 | Sep 10, 26 |
Anderson Dyaarl Lee Jr. Officer | Sold (automatic/other) | -2K | sold 2.3% | 76K | $4K at $2.00 | Sep 10, 26 |
Jackson Benjamin Officer | Sold (automatic/other) | -2K | sold 1.4% | 160K | $4K at $2.00 | Sep 10, 26 |
Lindgardt Zhenya Officer | Sold (automatic/other) | -20K 0.05% of company | sold 2.3% | 845K | $40K at $2.00 | Sep 8, 26 |
Gleason Scott Officer | Acquired (grant/award) | +118K 0.3% of company | n/a | 118K | n/a | Aug 31, 26 |
Barlow Jane F Director | Acquired (grant/award) | +24K 0.06% of company | added 100% | 47K | n/a | Jul 10, 26 |
Capone Mark Christopher Director | Acquired (grant/award) | +44K 0.1% of company | n/a | 44K | n/a | Jul 10, 26 |
Critchfield Gregory C Director | Acquired (grant/award) | +24K 0.06% of company | added 2.9% | 847K | n/a | Jul 10, 26 |
Kamdar Kim P. Director | Acquired (grant/award) | +26K 0.07% of company | added 79% | 58K | n/a | Jul 10, 26 |
Lawrence Sandra Aj Director | Acquired (grant/award) | +25K 0.06% of company | added 100% | 41K | n/a | Jul 10, 26 |
Mirza Mansoor Raza Director | Acquired (grant/award) | +24K 0.06% of company | added 42% | 82K | n/a | Jul 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in services-medical laboratories, closest in size first.
Here is the latest on SERA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SERA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SERA last traded at $2.08, up 0.72% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Sera Prognostics, Inc. Class A Common Stock (SERA) is next expected to report earnings on Thursday, November 12, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SERA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SERA 0 times in the last 30 days.
SERA (Sera Prognostics, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $82M in the Services-Medical Laboratories sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SERA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SERA discussion
Sign in to ask a question or join the discussion.